How Far Back Can a Blood Drug Test Detect Drug Use?

Blood drug tests generally detect most substances for a window of hours to a few days, far shorter than urine or hair testing. The exact lookback period depends heavily on which drug is involved: a substance like GHB may drop below detectable levels in blood within four to five hours, while a heavy cannabis user could show positive for THC metabolites for several days. That variability makes blood testing both more precise and more limited than people expect, and the choice of what exactly counts as “blood” in the sample adds another layer of complexity.

Why Blood Has a Narrower Detection Window Than Urine or Hair

Blood is a snapshot of what is actively circulating in your body right now. Once a drug enters the bloodstream, your liver and kidneys start breaking it down and pushing the metabolites out through urine. Blood concentrations peak quickly and then fall, sometimes within minutes. Urine, by contrast, accumulates those metabolites over hours and sometimes days, which is why urine tests can look further back. Hair testing captures drug traces deposited during hair growth and can reach back months.

This makes blood testing the preferred method when the question is “are you under the influence right now?” rather than “have you used drugs recently?” Roadside impaired-driving investigations, emergency room admissions, and workplace accident protocols often rely on blood draws precisely because they reflect current or very recent exposure. But it also means that timing matters enormously. A blood draw taken twelve hours after a single dose of many common drugs may come back clean, even though a urine test taken at the same moment would still be positive.

Detection Windows for Common Drugs

The ranges below reflect what research has shown for typical single or moderate doses in otherwise healthy adults. Chronic or heavy use can extend these windows, sometimes substantially.

Cannabis (THC)

THC enters the blood rapidly after smoking or vaping, often peaking within minutes, and then drops off fast. After a single use, blood THC is usually undetectable within a few hours. But THC is fat-soluble, so regular users build up stores in body fat that slowly leak back into the blood over days or even weeks. For someone who uses cannabis daily, trace levels of THC or its metabolites can linger in blood for several days after their last use. The practical detection window for a single episode is roughly two to six hours for the parent compound, while metabolites may persist for a day or two in occasional users and longer in heavy users.

Cocaine

Cocaine itself is cleared from blood quickly. After a single intranasal dose, peak concentrations in plasma reached about 380 ng/mL and fell from there as the body converted cocaine into its metabolites, primarily benzoylecgonine (BZE) and ecgonine methyl ester (EME).¹ Parent cocaine is usually undetectable in blood within about twelve hours of a single dose. Its metabolite BZE hangs around longer and can be picked up for roughly one to two days. In binge users or people with impaired liver function, the window may stretch further.

Amphetamines and Methamphetamine

After a single oral dose of methamphetamine, the drug appeared in plasma within fifteen minutes to two hours and reached peak levels within two to twelve hours. At 24 hours after a single dose, methamphetamine was still above the detection threshold in about half the participants studied.² In general, a blood test can detect amphetamines for about one to three days after a single use, depending on the dose and whether the person is a regular user.

Benzodiazepines

This is a broad class of drugs (diazepam, alprazolam, clonazepam, and others), and the detection windows vary widely within the group. Short-acting benzodiazepines like triazolam may clear the blood within six to twelve hours, while longer-acting ones like diazepam produce active metabolites that can remain detectable for days. Laboratory methods can reliably measure most benzodiazepines across whole blood, plasma, and serum, though some compounds like zopiclone are unstable and harder to quantify.³

GHB (Gamma-Hydroxybutyrate)

GHB has one of the shortest detection windows of any commonly tested drug. In a controlled study with two volunteers, serum GHB peaked at around 95 to 106 µg/mL within 20 minutes of ingestion and then plunged below 1 µg/mL within four to five hours.⁴ This is part of what makes GHB notoriously difficult to confirm in cases of suspected drug-facilitated assault: unless the blood draw happens within a few hours of exposure, the evidence may already be gone.

Opioids

The detection window varies by the specific opioid. Heroin is metabolized so rapidly that the parent drug is almost never found in blood; instead, labs look for 6-monoacetylmorphine and morphine, which persist for roughly six to twelve hours. Prescription opioids like oxycodone or hydrocodone generally remain detectable for one to two days. Methadone, which has a long half-life, can be found in blood for several days. Fentanyl, depending on the route and whether it was pharmaceutical or illicitly manufactured, can be detectable for about a day after a single exposure, though repeated use extends that.

Alcohol and Its Longer-Lasting Biomarker

Ethanol itself clears the blood quickly. The body metabolizes alcohol at a fairly steady rate, and with a half-life of roughly four to five hours, a standard blood alcohol test is mostly useful within hours of drinking.⁵ For heavy drinkers, a night of excess might still show measurable blood alcohol the next morning, but for most people the window is under twelve hours.

Where things get more interesting is with a biomarker called phosphatidylethanol, or PEth. PEth is a substance that forms in red blood cell membranes when ethanol is present, and it sticks around far longer than alcohol itself. In a study with 16 volunteers who drank a single moderate amount of alcohol, PEth was detectable in blood for three to twelve days afterward, with a half-life of about three days.⁶ In chronic heavy drinkers, PEth can remain elevated for weeks. This makes PEth testing a powerful tool for monitoring abstinence in treatment programs, probation settings, and organ transplant evaluations, because it catches drinking that a standard ethanol test would miss entirely.

Whole Blood, Plasma, or Serum: The Matrix Matters

When people say “blood test,” they usually picture a single vial of red liquid. In practice, labs can test whole blood (everything in the tube), plasma (the liquid portion after removing cells, with clotting factors still present), or serum (the liquid after cells and clotting factors are removed). These are not interchangeable. Drug concentrations can differ between them because some substances bind to red blood cells while others float freely in the liquid portion.⁷

For cocaine specifically, the ratio between whole blood and plasma concentrations was close to one for cocaine and its metabolites, meaning the drug distributes fairly evenly.¹ But for other drug classes the gap can be significant. When researchers validated methods for detecting neuroleptic drugs across all three sample types, they found more pronounced matrix effects in plasma and serum compared with whole blood.⁸ The practical takeaway is that the type of blood sample collected, and the reference ranges the lab uses, both affect whether a result is reported as positive or negative.

Why Blood Levels Do Not Always Equal Impairment

One of the most contentious issues around blood drug testing is the assumption that a higher blood concentration means a more impaired person. For alcohol and benzodiazepines, this relationship is fairly strong. A large forensic study found that the percentage of clinically impaired cases rose steeply as blood concentrations increased: from about 60% to 97% for ethanol and from 38% to 76% for benzodiazepines.⁹

For amphetamines and THC, though, the connection was much weaker. The same study showed that impairment rates climbed only modestly from lower to higher concentrations: from about 43% to 58% for amphetamines and from 41% to 55% for THC.⁹ The statistical correlation between blood THC and actual impairment was low. Separate research on cannabis found that after inhalation, blood THC concentrations often returned to baseline well before the cognitive and psychomotor effects had worn off.¹⁰ In other words, a person could be noticeably impaired from cannabis but have a blood THC level that looks unremarkable, or the reverse, have a detectable level days later while feeling perfectly sober.

This disconnect is why using blood drug concentrations as a straightforward proxy for impairment, the way blood alcohol concentration works for drunk driving, remains scientifically problematic for many substances. Legal systems often set per se limits anyway, but the science behind those limits is far less settled for drugs other than alcohol.

Fat Storage and the Cannabis Complication

THC’s unusually long detection window in heavy users comes down to its affinity for fat tissue. Research on fat-soluble compounds has shown that adipose tissue acts as a long-term reservoir, slowly releasing stored molecules back into circulation.¹¹ THC behaves similarly: it accumulates in fat during periods of use and trickles out over days or weeks once a person stops. This is why a daily cannabis user can test positive in blood long after their last session, while someone who tried it once at a party would likely be clear within a day. Body composition matters here, too. A person with a higher percentage of body fat may retain THC longer than a leaner person, though the practical difference is hard to predict for any individual.

Exercise can temporarily spike blood THC levels in regular users by mobilizing fat stores, which is a curiosity that occasionally comes up in discussions about drug testing for athletes. Whether that bump is large enough to push someone over a testing threshold depends on the individual and how much THC they have stored, but it underscores the point that blood THC levels in chronic users reflect accumulated exposure, not just recent intake.

The Challenge of Novel and Designer Drugs

Synthetic cannabinoids (sometimes sold under names like “Spice” or “K2”) and synthetic cathinones (“bath salts”) present a distinct problem for blood testing. Their chemical structures change constantly as manufacturers tweak formulas to evade regulations, which means standard testing panels may not even include the right target compounds. Labs need analytical methods flexible enough to keep up with these structural shifts.¹²

Modern liquid chromatography-mass spectrometry methods have pushed detection limits impressively low, in some cases down to 0.1 ng/mL for hallucinogens, synthetic cathinones, and synthetic cannabinoids.¹³ But sensitivity alone does not solve the problem if the lab does not know to look for a particular substance. Many novel psychoactive substances go undetected not because they clear the blood too quickly, but because they were never on the test menu. If you or someone you know used a substance with an unfamiliar name, a standard blood drug screen may miss it entirely unless a more comprehensive panel is specifically ordered.

How Sample Handling Affects Results

A blood sample is not frozen in time the moment it leaves your vein. How it is stored and how long it sits before analysis can change the result. Most drugs remain stable in blood kept refrigerated or frozen, but at room temperature, degradation starts to chip away at accuracy.¹⁴ Drugs with ester groups or easily oxidized structures are especially vulnerable.

Synthetic cannabinoids illustrate this well. When researchers tracked how several synthetic cannabinoid compounds held up over time in stored blood samples, they found a gradual decline in concentrations, with one compound (5F-MDMB-PINACA) degrading fastest. Storing samples at −20°C slowed this considerably, while room-temperature storage accelerated it.¹⁵ In forensic and legal settings, poor sample handling could mean the difference between a positive and a negative result, and defense attorneys sometimes raise storage conditions as a challenge to blood evidence.

Postmortem Blood Testing Is a Different Animal

After death, blood drug testing follows entirely different rules. A phenomenon called postmortem redistribution causes drugs to leak from organs like the liver, lungs, and heart muscle back into the surrounding blood.¹⁶ The result is that blood drug concentrations measured at autopsy may be substantially higher or lower than what was actually present at the time of death, depending on where in the body the blood was sampled and how much time passed.¹⁷

The mechanisms behind this include passive diffusion from drug-rich organs into adjacent blood, breakdown of cell membranes after death, blood pooling due to gravity, and eventually the decomposition process itself.¹⁸ Forensic toxicologists account for this by preferring blood drawn from the femoral vein (in the thigh, far from major organs), but even with that precaution, interpreting postmortem drug levels requires significant caution. A postmortem blood concentration cannot simply be compared to a living person’s reference range and treated as equivalent. This is one reason death investigations involving drug toxicity often require a toxicologist’s expert interpretation rather than just a lab number.

When People Get Blood Testing Timelines Wrong

The most common misconception is applying urine testing windows to blood tests. Someone who reads that marijuana is detectable “for up to 30 days” and assumes blood testing works the same way is conflating two very different methods. That 30-day figure comes from urine testing of metabolites in chronic heavy users. In blood, even a heavy user rarely shows THC beyond a week, and a single-use scenario clears in hours. On the flip side, people sometimes assume a negative blood test means they were not exposed to a drug at all, when it may simply mean too much time elapsed between use and the blood draw, especially for fast-clearing substances like GHB.

Another frequent misunderstanding involves “detox” products marketed as ways to beat a blood test. Because blood reflects what is actively circulating, there is no realistic way to flush a drug from your bloodstream faster than your liver and kidneys are already doing it. Drinking large amounts of water, a strategy that dilutes urine metabolite concentrations, has negligible impact on blood drug levels. The body’s own metabolism is the clock, and no commercially available supplement speeds it up in a meaningful way.

Individual variation also trips people up. Two people who use the same amount of the same drug can have meaningfully different detection windows based on their metabolism, body weight, liver function, hydration, and how often they use the substance. Published detection windows are population averages and ranges, not guarantees for any one person. A chronic user with slow metabolism will sit at the long end of the range, while a one-time user with a fast metabolism will sit at the short end, and there is no simple formula to predict where you fall.